Examples of influential post-regulatory evidence evaluators and decision makers.
| Main Stakeholder Group | Subgroup | Examples |
|---|---|---|
| Payers/purchasers | Public | • Medicare/Medicaid (US) |
| • Provincial ministries of health (Canada) | ||
| Private | • Health insurance companies | |
| • Health maintenance organizations | ||
| • Employers | ||
| • Pharmaceutical benefit managers (e.g., ExpressScripts, CVS/Caremark, Optum) | ||
| Policymakers | Formulary committees | • Individual health systems |
| • Hospital-level, district, or regional health authority | ||
| • State or provincial level | ||
| Clinical practice guideline developers | • American College of Rheumatology | |
| • Asia Pacific League of Associations for Rheumatology | ||
| • Australian Rheumatology Association | ||
| • Canadian Rheumatology Association | ||
| • European League Against Rheumatism | ||
| • International League of Associations for Rheumatology | ||
| • NICE | ||
| • Pan-American League of Associations for Rheumatology | ||
| Principal investigators and evidence review groups | HTA groups | • Canadian Agency for Drugs and Technologies in Health |
| • ECRI Institute, Hayes Inc. | ||
| • HTA international | ||
| • NIHR-HTA | ||
| Systematic reviewers | • Cochrane | |
| • Evidence-based Practice Centers | ||
| • Agency for Healthcare Research and Quality | ||
| Value-framework organizations | • Institute for Clinical and Economic Review | |
| • NICE | ||
| • NIHR | ||
| Decision modelers | • International Society for Pharmacoeconomics and Outcomes Research | |
| • Society for Medical Decision Making, numerous academic groups |
NICE: UK National Institute for Health and Care Excellence; HTA: Health Technology Assessment; NIHR: UK National Institute for Health Research.